DRUGS VALUE IN AMERICA
Drugs’ value In America v. Other Countries
Instructions:
Unit 6 Debate : Costs of drugs in the United States as compared to other countries
- Group Leader- Be sure you have audio working and Word document for both Pro and Con side prior to submission.
- Group Leader- Remember, if you have a member of the group who is not completed- submit anyway. The student who is not completed will need to contact me.
- APA will be each individual’s responsibility to correct –not the leader.
- People for con: Shereen Robinson
- Title slide- Shereen Robinson (con)
- Declare that a certain policy should or should not be created-
- What effects will the policy change have on stakeholders? Why, or why not, is this policy important? Shereen Robinson (con)
- What are the costs to stakeholders?
- Important issues and research to support your position. Shereen Robinson (con)
- Conclusion- Shereen Robinson (con)
- Word document-
Link- Must be present in Word Document-
Solution.
Drugs’ value In America v. Other Countries
Research shows that Americans spend more money on drugs than other countries globally. Consequently, Congress is pushing for policies that will reduce these prices to favor the patients and save taxpayer money. However, formulating these policies will have negative consequences on the sick patients, the elderly and discourage investors from investing in the drug industry (Howard, 2015).
Reduced drug costs have a negative impact on the innovation process of medicines (Nordrum, 2015). Investors will not invest in a field that does not provide good returns and profit. Regulatory policies will impact negatively on the companies that want to introduce new drugs but lack capital. It will also reduce the morale of pharmacists to generate new ideas for drugs aimed at curbing stubborn diseases. As a result, the pharmaceutical field will lack the equipment and expertise to cure current diseases and prevent future ones.
The sick will also suffer thereby increasing their mortality rate. Seniors will lack the drugs that assist them in some of the ailments that develop in later stages of human development. Therefore, reducing medicinal costs may save money presently at the expense of future generations and the life of chronically ill people. Moreover, America’s high medicine prices assist in reducing drug research globally (Kliff, 2016). New drugs have resulted from this investigation and innovation, which have cured conditions that were regarded fatal in the past. Curtailing this process will not only affect Americans but also citizens in the world.
In conclusion, people should
forecast and make decisions that benefit the sick and elderly, save lives and
encourage innovation in the pharmaceutical world. Introducing policies that
reduce drug costs will result in more harm than the intended benefits.
References
Howard, P. (2015). To Lower Drug Prices, Innovate, Don’t Regulate. The New York Times.
Kliff, S. (2016). The true story of America’s sky-high prescription drug prices. Vox.
Nordrum, A. (2015). Should Government Control The Price Of Prescription Drugs?. International Business Times.
